Abatacept therapy for rheumatoid arthritis in the setting of hepatitis C infection

Journal of Clinical Rheumatology

Volumn 16, Issue 7, 2010, Pages 332-334

  Mahajan, Tina Dewan ^a   Hooker, Roderick ^a   Maher, Lisa ^a   Brown, Geri ^a   Reimold, Andreas ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Abatacept; hepatitis C infection; rheumatoid arthritis

Indexed keywords

ABATACEPT; ADALIMUMAB; ETANERCEPT; INFLIXIMAB; METHOTREXATE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIOLOGICAL THERAPY; CASE REPORT; CHRONIC HEPATITIS; DISEASE ACTIVITY; DISEASE DURATION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INJECTION SITE REACTION; INTRAVENOUS DRUG ABUSE; LIVER FIBROSIS; LIVER TOXICITY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; SIDE EFFECT; VIRUS LOAD;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HEPATITIS C; HUMANS; IMMUNOCONJUGATES; MALE; MIDDLE AGED;

EID: 78049235054     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3181f4cd92     Document Type: Article

References (7)

1. Rustgi VK. The epidemiology of hepatitis C infection in the United States. J Gastroenterol 2007;42:513-521.
2. Parke FA, Reveille JD. Anti-tumor necrosis factor agents for rheumatoid arthritis in the setting of chronic hepatitis C infection. Arthritis Rheum 2004;51:800-804.
3. Afdhal NH. The natural history of hepatitis C. Semin Liver Dis 2004;24:3-8.
4. Cacaoub P, Paynard T, Ghilani P, et al. Extrahepatic manifestations of chronic hepatitis C. Arthritis Rheum 1999;42:2204-2214.
5. Ferri C, Govoni M, Calabrese L. The A, B, Cs of viral hepatitis in the biologic era. Curr Opin Rheum 2010;22:1-8.
6. Buch MH, Vital E, Emery P. Abatacept in the treatment of rheumatoid arthritis. Arthritis Res Ther 2008;10(suppl 1):S5.
7. Kyrlagkitsis I, Portmann B, Smith H, et al. Liver histology and progression of fibrosis in individuals with chronic hepatitis C and persistently normal ALT. Am J Gastroenterol 2003;98:1588-1593.